title: Bromocriptine-induced schizophrenia.
abstract: A 53-year-old male, without any prior history of psychosis, developed schizophrenia 4 days after starting low-dose bromocriptine therapy for a macroprolactinoma. Five days after discontinuation of this medication his mental status returned to normal. This case is reported in support of the dopamine hypothesis for the etiology of schizophrenia.
authors.affiliation: Department of Medicine, St Mary's Hospital of Brooklyn, New York 11213.
authors.forename: S A
authors.initials: SA
authors.lastname: Peter
authors.forename: A
authors.initials: A
authors.lastname: Autz
authors.forename: M L
authors.initials: ML
authors.lastname: Jean-Simon
mesh_terms: D001971:Bromocriptine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy; D015175:Prolactinoma / Q000188:drug therapy; D012559:Schizophrenia / Q000139:chemically induced*
chemical_list: D001971:Bromocriptine